It is a highly aggressive hematopoietic neoplasm that is associated with rearrangements between the genes encoding retinoic acid receptor alpha (RARα) or other members of the retinoic acid receptor (RAR) family and several partner genes [2,3]. Here, RARA is linked to hematopoietic and lymphoid cell neoplasm.